TickerFactsScreenerDevelopers

Oncotelic Therapeutics, Inc. (OTLC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $18.27M2009: $13.93M2010: $4.60M2011: $9.97M2012: $4.95M2014: $30.03M2015: $27.29M2016: $3.54M2017: $1.11M2018: $2.5K2019: $82.0K2020: $474.0K2021: $568.8K2022: $241.5K2023: $170.4K$170.4K
2008Cash & Equivalents (USD)2023
Fiscal YearCash & EquivalentsChange YoY
2023$170.4K-29.4%
2022$241.5K-57.5%
2021$568.8K+20.0%
2020$474.0K+478.3%
2019$82.0K+3181.2%
2018$2.5K-99.8%
2017$1.11M-68.5%
2016$3.54M-87.0%
2015$27.29M-9.1%
2014$30.03M—
2012$4.95M-50.4%
2011$9.97M+116.7%
2010$4.60M-67.0%
2009$13.93M-23.8%
2008$18.27M—